跳至主要内容
临床试验/CTRI/2024/01/061750
CTRI/2024/01/061750尚未招募3 期

Differential expression of Apolipoprotein A-IV (ApoA-IV) and Thioredoxin interacting protein (TXNIP) in the plasma of Madhumeha (Type 2 Diabetes Mellitus) patients treated with Shilajatu Darvi Yoga: An Exploratory Clinical Trial - NI

Prof Dr Tanuja Nesari0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Fasting plasma glucose: = 126 mg/dL – 200 mg/dL
  • 2.2-h plasma glucose: >200 mg/dL – 350 mg/dL
  • 3.Symptoms of diabetes plus random blood glucose = 200 mg/dl.
  • 4.HbA1C: 6.5% - 10%
  • 5.Patients in between 40 and 60 years of either sex.

排除标准

  • 1.Patients of type-1 diabetes mellitus.
  • 2.Cases with severe diabetic complications such as cardiac disease, nephropathy, and foot ulcer.
  • 3.Patients with chronic diseases such as Tuberculosis, Bronchial asthma, Chronic renal
  • failure, HIV, and Hepatitis.
  • 4.Patient below 40 years and above 60 years.
  • 5.Patients taking medication that may cause rapid glucose rise e.g. steroids, antipsychotics.
  • 6.Patients with acute pancreatic damage, including pancreatic surgery.
  • 7.Pregnancy.

研究者

发起方
Prof Dr Tanuja Nesari

相似试验